A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Clarke, Megan ^a   Schiffman, Mark ^a   Wacholder, Sholom ^a   Rodriguez, Ana Cecilia ^b   Hildesheim, Allan ^a   Quint, Wim ^c   Lowy, Douglas R ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Proyecto Epidemiologico Guanacaste   (Costa Rica)

^c Delft Diagnostic Laboratories   (Netherlands)

^d HPV Virologist   (United States)

Author keywords

Absolute risk; Human papillomavirus; Risk factors; Sexual behavior

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGE; ALPHAPAPILLOMAVIRUS; ARTICLE; CONTROLLED STUDY; COSTA RICA; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; INCIDENCE; INFECTION RISK; MONOGAMY; MULTIVARIATE ANALYSIS; PAPILLOMAVIRUS INFECTION; PHASE 3 CLINICAL TRIAL; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SURVIVAL; VACCINATION; WART VIRUS;

EID: 84879810398     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-308     Document Type: Article

References (29)

1. Winer RL, Feng Q, Hughes JP, O'Reilly S, Kiviat NB, Koutsky LA. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008, 197:279-282. 10.1086/524875, 2875685, 18179386.
2. Burchell AN, Winer RL, de Sanjose S, Franco EL. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006, 24(Suppl 3:S3):52-61.
3. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998, 338:423-428. 10.1056/NEJM199802123380703, 9459645.
4. Kemp TJ, Hildesheim A, Safaeian M, Dauner JG, Pan Y, Porras C, Schiller JT, Lowy DR, Herrero R, Pinto LA. HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection. Vaccine 2011, 29:2011-2014. 10.1016/j.vaccine.2011.01.001, 3046309, 21241731.
5. Burk RD, Ho GY, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 1996, 174:679-689. 10.1093/infdis/174.4.679, 8843203.
6. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, Koutsky LA. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006, 354:2645-2654. 10.1056/NEJMoa053284, 16790697.
7. Wawer MJ, Tobian AA, Kigozi G, Kong X, Gravitt PE, Serwadda D, Nalugoda F, Makumbi F, Ssempiija V, Sewankambo N, et al. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in rakai, uganda. Lancet 2011, 377:209-218. 10.1016/S0140-6736(10)61967-8, 3119044, 21216000.
8. Herrero R, Hildesheim A, Rodriguez AC, Wacholder S, Bratti C, Solomon D, Gonzalez P, Porras C, Jimenez S, Guillen D, et al. Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in guanacaste, costa rica. Vaccine 2008, 26:4795-4808. 10.1016/j.vaccine.2008.07.002, 2652516, 18640170.
9. Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, Abrahamsen M, Inserra P, Olvera S, Hatch K. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the young Women's health study. J Infect Dis 2002, 186:462-469. 10.1086/341782, 12195372.
10. Nielsen A, Iftner T, Munk C, Kjaer SK. Acquisition of high-risk human papillomavirus infection in a population-based cohort of danish women. Sex Transm Dis 2009, 36:609-615. 10.1097/OLQ.0b013e3181a96d0e, 2789348, 19955872.
11. Muñoz N, Méndez F, Posso H, Molano M, Van Den Brule AJC, Ronderos M, Meijer C, Muñoz T. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of colombian women with normal cytological results. J Infect Dis 2004, 190:2077-2087. 10.1086/425907, 15551205.
12. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, Rohan TE. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999, 180:1415-1423. 10.1086/315086, 10515798.
13. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001, 285:2995-3002. 10.1001/jama.285.23.2995, 11410098.
14. de Sanjose S, Bosch FX, Munoz N, Shah K. Social differences in sexual behaviour and cervical cancer. IARC Sci Publ 1997, 309-317.
15. Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV, Jara AT, Puschel KI, Robles SC, et al. Population-based prevalence and age distribution of human papillomavirus among women in santiago, chile. Cancer Epidemiol Biomarkers Prev 2004, 13:2271-2276.
16. Chan PK, Chang AR, Cheung JL, Chan DP, Xu LY, Tang NL, Cheng AF. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types. J Infect Dis 2002, 185:28-35. 10.1086/338010, 11756978.
17. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002, 2:372-377. 10.1038/nri803, 12033743.
18. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, Ning L, Killeen J, Kamemoto L, Hernandez BY. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: hawaii human papillomavirus cohort study. Cancer Research 2008, 68:8813-8824. 10.1158/0008-5472.CAN-08-1380, 2727731, 18974124.
19. Sellors JW, Karwalajtys TL, Kaczorowski J, Mahony JB, Lytwyn A, Chong S, Sparrow J, Lorincz A. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003, 168:421-425. 143547, 12591782.
20. Lazcano-Ponce E, Herrero R, Munoz N, Cruz A, Shah KV, Alonso P, Hernandez P, Salmeron J, Hernandez M. Epidemiology of HPV infection among mexican women with normal cervical cytology. Int J Cancer 2001, 91:412-420. 10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M, 11169968.
21. Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001, 183:1554-1564. 10.1086/320696, 11343204.
22. Marks M, Gravitt PE, Gupta SB, Liaw KL, Tadesse A, Kim E, Phongnarisorn C, Wootipoom V, Yuenyao P, Vipupinyo C, et al. Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from thailand. J Infect Dis 2011, 204:1505-1513. 10.1093/infdis/jir560, 3222104, 21964399.
23. Tobian AA, Gray RH. Male foreskin and oncogenic human papillomavirus infection in men and their female partners. Future Microbiol 2011, 6:739-745. 10.2217/fmb.11.59, 21797689.
24. Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002, 346:1105-1112. 10.1056/NEJMoa011688, 11948269.
25. Albero G, Castellsague X, Giuliano AR, Bosch FX. Male circumcision and genital human papillomavirus: a systematic review and meta-analysis. Sex Transm Dis 2012, 39:104-113. 10.1097/OLQ.0b013e3182387abd, 22249298.
26. Rylander E, Ruusuvaara L, Almstromer MW, et al. The absence of vaginal human papillomavirus 16 DNA in women who have not experienced sexual intercourse. Obstet Gynecol 1994, 83:735-737.
27. Winer RL, Lee S, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003, 157:218-226. 10.1093/aje/kwf180, 12543621.
28. United Nations Department of Economic and Social Affairs Population Division World contraceptive Use 2009 2007, Geneva, Switzerland: World Health Organization HIV/AIDS Department, Available at http://www.un.org/esa/population/publications/contraceptive2009/contracept2009_wallchart_front.pdf. Accessed February 20, 2013, United Nations Department of Economic and Social Affairs Population Division.
29. United Nations, Department of Economic and Social Affairs, Population Division World Contraceptive Use 2009 (POP/DB/CP/Rev2009) 2009, New York, NY, United Nations, Department of Economic and Social Affairs, Population Division.